 Home > Medical News > Latest Medical News > Kangyuan Pharmaceutical focuses on the research and development of new drugs, and the price of raw materials such as Zhejiang shellfish has increased!

Kangyuan Pharmaceutical focuses on the research and development of new drugs, and the price of raw materials such as Zhejiang shellfish has increased!

 Last Update: 2022-09-30
 Source: Internet
 Author: User

Tags

4 2 encoder

sound health medical supply

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The 2022 semi-annual performance report disclosed by Jiangsu Kangyuan Pharmaceutical Co.
, Ltd.
(Kangyuan Pharmaceutical, 600557) shows that during the reporting period, the company's performance data continued the growth trend in 2021, achieving a total revenue of 2.
097 billion yuan, an increase of 18.
54% year-on-year; The net profit attributable to the shareholders of the listed company was 211 million yuan, an increase of 32.
35%
year-on-year.

Figure 1: Kangyuan Pharmaceutical's core operating indicators for 2017-2022

First, there are many exclusive varieties

At present, Kangyuan Pharmaceutical has 203 drug production approvals, including 43 exclusive varieties of traditional Chinese medicine and 2 varieties of traditional Chinese medicine protection
.
The main product line focuses on the advantages of traditional Chinese medicine such as viral infectious diseases, gynecological diseases, cardiovascular and cerebrovascular diseases, orthopedic diseases, etc.
, among which the representative varieties of the viral infectious disease product line are Jinzhen oral liquid, hot poison Ning injection, apricot cough granules and so on
.

Table 1: List of exclusive products of Kangyuan Pharmaceutical

According to Intranet data, in 2021, the sales of apricot shell cough granules in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) exceeded 90 million yuan, an increase of 61.
92%
year-on-year.

In this issue, the big data platform of the traditional Chinese medicine industry of Tiandi Cloud Map will briefly evaluate
the cost pressure of traditional Chinese medicine raw materials of enterprises from the perspective of raw materials involved in Xingbei cough granules.

Second, the core raw material of apricot shell cough granules

Table 2: Apricot shell cough granules core raw material table

The product can clear the lungs, relieve cough and dissolve phlegm, and is used to treat external cough is a cold and hot certificate on the surface, and the symptoms are micro-chills, fever, cough, phlegm, phlegm thick stickiness, dry mouth, irritability, etc
.

Third, the raw materials of apricot shell cough granules rise and fall

Table 3: Apricot shell cough granule raw material rise and fall table

From January 2021 to September 2022, the price of 7 kinds of raw materials increased, accounting for 78%, the price of 1 raw material fell, accounting for 11%, and the price of one raw material flattened, accounting for 11%.

Fourth, apricot shell cough granules raw material reviews

Ephedra, Inner Mongolia production area began to produce new, the production market is stable, it is expected that this year's output is not much
different from last year.
This variety belongs to the market control of the exclusive varieties, pay attention to the limited business, the market remains stable, the market general slice unified goods price of 17-18 yuan (kilogram price, the same below), it is expected that the market will run
smoothly in the short term.

Bitter almonds, the origin began to produce new, the source of goods in the place of origin slowed down, the price was weak, the price fell in the early stage of the market, and the recent market stabilized
.
With the increase of market arrivals, the overall attention is not high, the price has not changed much compared with the previous period, the market price of unified goods is 26-27 yuan, with a large number of new goods into the market, the price may
change.

Platycodon, Inner Mongolia production area has begun to dig, the price of fresh goods in the place of origin is 5-5.
3 yuan; Hebei also has new goods output, the local unified goods are priced at around 29-30 yuan; Shaanxi and other real estate is approaching, the market supply is not much, and the new goods are listed less
.
Merchants pay attention to the new production situation this year, and it is expected that the market will fluctuate
in the future.

Qianhu, there are merchants in the place of origin looking for goods, and the price has risen; The market enters the peak demand season, with the consumption of inventory, the source of goods is accelerating, and the price of unified goods in the market is around 36-37 yuan
.
Due to the abundant inventory, the future market needs to pay attention to the
market consumption.

Zhejiang shellfish, the production area transaction volume is not large, farmers are reluctant to sell, the overall market attention is not high, the market is the same as the previous period, the market sulfur-free price is between 54-57 yuan, the price of sulfur-free tablets is between 72-75 yuan, and the market runs
smoothly in the short term.

100 parts, the production of new real estate, the origin of fresh goods priced at 4.
5 yuan / kg up and down, folded dry products priced at 36 yuan or more; The market has new goods into the market, the overall inventory is not much, the price remains firm and running, the current market price of unified goods is 37 yuan or more, and the price of unified pieces is 45 yuan
.
It is expected that this year's production is not large, and the price may
change in the future.

North sand ginseng, the production of new real estate, new goods have been listed, Inner Mongolia production area this year increased, but due to weather reasons led to a decrease in mu production, Inner Mongolia fresh goods price of 5-6 yuan, 90% of the dry goods price of 45 yuan or so; Hebei goods also entered the market in large quantities, the local unified price of 26-30 yuan, the dryness is generally not good, the overall movement is acceptable, and the merchants pay attention to this year's
output.

Wood butterfly, high price to stimulate the arrival of goods at the port, the market supply is volume, the overall demand is limited, the source of goods is slow, the market has declined, the current market price is 40-41 yuan, the attention of merchants is not high, and the market is flat
.

5.
Comprehensive analysis

1, Zhejiang shellfish and other varieties of procurement cost pressure is relatively large raw material pressure test shows that the current apricot shell cough granules raw materials from the supply pressure, mainly from Zhejiang shellfish, North Sand Ginseng, Qianhu and Baibu, etc.
; From the perspective of quality pressure, it mainly comes from Qianhu, Zhejiang Beimu and Baibu
.

2, Zhejiang shellfish production in 2022 In 2020, the Zhejiang shellfish market bottomed out, farmers have abandoned seeds, seeds were sold as finished products, resulting in a sharp rise in seed prices in 2021, and the planting area was further reduced
.
In 2022, the drought in Zhejiang's production areas, the reduction of seed output, coupled with the limited planting area, led to a steady increase
in the market after the new production.

However, the planting area of Hubei shellfish in recent years is not small, and the yield can already be comparable to that of Zhejiang production areas
.
In addition, Zhejiang oysters are asexually propagated, and one Zhejiang oyster is planted that year, and only two new oysters
can be produced after the mother decays in the second year.
If one of the new shellfish is used to process the commodity and the other continues to be used for cultivation, it is difficult to expand the yield, but the yield reduction can be achieved
by controlling the scallops.
In the future, the price of Zhejiang shellfish will also need to pay attention to capital trends and the
growth of actual demand.

3.
Kangyuan Pharmaceutical vigorously invests in new drug research and development In 2021, Kangyuan Pharmaceutical invested 499 million yuan in research and development expenses, an increase of 31.
27% year-on-year; R&D expenses in the first half of 2022 were 277 million yuan, an increase of 28.
01%
year-on-year.
With the acceleration of drug approval, as well as the impact of new pharmaceutical policies such as collection, medical insurance, and consistency evaluation, the domestic innovative drug track is moving towards spring, how to avoid homogenization competition, shorten the research and development cycle, reduce research and development costs, and improve profit margins is the basis
of the company's future competition.

Figure 1: Kangyuan Pharmaceutical's core operating indicators for 2017-2022

First, there are many exclusive varieties

Medicines and medicines

Table 1: List of exclusive products of Kangyuan Pharmaceutical

Hospital Hospital

Enterprise enterprise

Second, the core raw material of apricot shell cough granules

Table 2: Apricot shell cough granules core raw material table

Third, the raw materials of apricot shell cough granules rise and fall

Table 3: Apricot shell cough granule raw material rise and fall table

Fourth, apricot shell cough granules raw material reviews

<>.
Comprehensive analysis

5.
Comprehensive analysis

Procurement procurement

Medicine and medicine

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.